South Korea's Celltrion Tops Samsung Biologics in Q3 Revenue as Annual Race Tightens - finance.biggo.com
South Korea's Celltrion Tops Samsung Biologics in Q3 Revenue as Annual Race Tightens finance.biggo.com
Related discussion groups
No group discusses this yet. Start a discussion group and attach this story.
More news about South Korea
- South Korea growth tops forecast as chip boom masks weak demandA contraction in consumption underscored an increasingly uneven expansion that may complicate the trajectory for further interest-rate hikes.
- Samsung Life Prices Record Dollar Bond as Investors Defy TurmoilAn affiliate of Samsung Group sold the biggest dollar bond sale for a South Korean insurer as investors braved volatile debt markets that have forced some companies to pull their planned debt offer...
- Tax revenue estimates go off mark due to outdated forecast models: state auditorSEOUL, Oct. 27 (Yonhap) -- Differences between the government's tax revenue esti...
- FTC to slap 20 bln-won fine on Samsung Electronics for misleading gaming adsSEOUL, Oct. 27 (Yonhap) -- South Korea's antitrust watchdog said Tuesday it has ...
- (LEAD) Supreme Court finalizes 3-yr prison term for ex-commander over Marine's deathSEOUL, Oct. 27 (Yonhap) -- The Supreme Court on Tuesday finalized a three-year p...
- (LEAD) Lee says S. Korea should learn from European protests to sustain growthSEOUL, Oct. 27 (Yonhap) -- President Lee Jae Myung said Tuesday that South Korea...
- AI shoppers get first say in South Korea’s retail race - Asia News NetworkAI shoppers get first say in South Korea’s retail race Asia News Network
- SCIA chief attends Cabinet meeting for 2nd time amid controversySEOUL, Oct. 27 (Yonhap) -- Kim Ji-yong, the inaugural chief of the Serious Crime...